Literature DB >> 23230094

The discriminatory capacity of ultrasound in rheumatoid arthritis: active vs inactive, early vs advanced, and more.

Marcin Szkudlarek1, Richard J Wakefield, Marina Backhaus, Lene Terslev.   

Abstract

This review presents data about the discriminatory role of US in differentiating findings between healthy people and patients with RA and arthritides, comparisons between active and inactive changes in RA, as well as between early and advanced changes in RA as visualized with US. The theoretical basis of discriminatory capacity is sketchy and the few studies that provide evidence of its use when assessing RA patients with US are discussed. We also suggest directions for potential research areas.

Entities:  

Mesh:

Year:  2012        PMID: 23230094     DOI: 10.1093/rheumatology/kes334

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

Review 1.  Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Authors:  Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

2.  Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.

Authors:  Espen A Haavardsholm; Anna-Birgitte Aga; Inge Christoffer Olsen; Siri Lillegraven; Hilde B Hammer; Till Uhlig; Hallvard Fremstad; Tor Magne Madland; Åse Stavland Lexberg; Hilde Haukeland; Erik Rødevand; Christian Høili; Hilde Stray; Anne Noraas; Inger Johanne Widding Hansen; Gunnstein Bakland; Lena Bugge Nordberg; Désirée van der Heijde; Tore K Kvien
Journal:  BMJ       Date:  2016-08-16

3.  Analysis of distribution and severity of inflammation in patients with osteoarthitis compared to rheumatoid arthritis by ICG-enhanced fluorescence optical imaging and musculoskeletal ultrasound: a pilot study.

Authors:  A-M Glimm; S G Werner; G R Burmester; M Backhaus; S Ohrndorf
Journal:  Ann Rheum Dis       Date:  2015-08-26       Impact factor: 19.103

4.  Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.

Authors:  Jana Hurnakova; Hana Hulejova; Jakub Zavada; Martin Komarc; Petra Hanova; Martin Klein; Herman Mann; Olga Sleglova; Marta Olejarova; Sarka Forejtova; Olga Ruzickova; Jiri Vencovsky; Karel Pavelka; Ladislav Senolt
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

5.  The agreement between ultrasound-determined joint inflammation and clinical signs in patients with rheumatoid arthritis.

Authors:  Xiaoying Sun; Xuerong Deng; Wenhui Xie; Liujun Wang; Yu Wang; Zhuoli Zhang
Journal:  Arthritis Res Ther       Date:  2019-04-17       Impact factor: 5.156

6.  A Longitudinal Study of the 28 Joints of Disease Activity Score by Ultrasonographical Examination in Rheumatoid Arthritis Patients.

Authors:  Rabab Hussin Ali; Osama Sayed Daifallah; Hanan Sayed M Abozaid; Esam Mohmad Abu Alfadl; Sahar Abdel-Rahman Elsayed
Journal:  J Med Ultrasound       Date:  2019-01-08

7.  Relapse in rheumatoid arthritis patients undergoing dose reduction and withdrawal of biologics: are predictable factors more relevant than predictive parameters? An observational prospective real-life study.

Authors:  Olivier Vittecoq; Sandra Desouches; Marie Kozyreff; Julia Nicolau; Sophie Pouplin; Pascal Rottenberg; Nicolas Sens; Thierry Lequerre; Gilles Avenel
Journal:  BMJ Open       Date:  2019-12-18       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.